Residual risk in patients treated with statins from the very high risk group of development atherogenic dyslipidemia. A prospective study "CRYSTAL" Part 1: Purpose, objectives, design, and baseline characteristics of the included patients
Keywords:
residual risk, atherogenic dyslipidemia, statins, CRYSTAL, prospective studyAbstract
This article is the first publication of data of a prospective, observational study "CRYSTAL" - the study of residual
risk in patients with very high risk of cardiovascular disease and atherogenic dyslipidemia, treated with statins. The
description of the purpose, objectives, design, and baseline characteristics included major patients. The data are
compared with the results of Russian and International Studies of residual cardiovascular risk factors.
Downloads
Download data is not yet available.
Downloads
Published
2013-03-30
How to Cite
Zubareva M. Y., Rozhkova T. A., Gornyakova N. B., Solov’eva E. Y., Kukharchuk V. V., Amelyushkina V. A., Kotkina T. И., Titov V. N., Susekov A. V. Residual risk in patients treated with statins from the very high risk group of development atherogenic dyslipidemia. A prospective study "CRYSTAL" Part 1: Purpose, objectives, design, and baseline characteristics of the included patients // The Journal of Atherosclerosis and Dyslipidemias. 2013. VOL. № 1 (10). PP. 26–34.
Issue
Section
Original research paper